31 October 2018

Tagworks to present at the European Antibody Congress in Basel

Read more
15 November 2018

Tagworks to present at the World ADC meeting in San Diego

Read more


Tagworks Pharmaceuticals is developing a unique approach towards antibody-based imaging and therapy. Tagworks’ technology enables the actuation of tagged antibodies through selective chemical manipulation in vivo, improving the efficacy of established approaches such as Radioimmuno-imaging and –therapy and Antibody-Drug Conjugates.

More on the Tagworks approach


4 July 2018

Just published in Angewandte Chemie: ‘click-to-release’… more

Tagworks reports that the scope of its proprietary click-to-release reaction can be expanded from the cleavage of carbamates to ethers,…
Read more

4 May 2018

Tagworks publishes convincing results of cancer therapy in mice in Nature Communications

In mouse models of ovarian and aggressive colon cancer, Tagworks Pharmaceuticals has demonstrated the potent antitumour effect of the company’s…
Read more

27 June 2017

Tagworks featured in BioCentury

Tagworks is featured in a BioCentury article on the state of the art and clinical prospects of in vivo click…
Read more